New Delhi [India], February 8: In the current scenario of triple planetary crises, environmental stewardship and visionary leadership are indispensable elements for fostering collective action and propelling global efforts to address shared environmental challenges. With the above backdrop,
At a time when people in Afghanistan are grappling with economic woes under Taliban rule, the former President of the country, Hamid Karzai, has underscored the importance of the Doha meeting for Afghanistan and expressed hope for positive steps from global powers during the event.
Pakistan is all set to go for general elections tomorrow on February 8, however, concerns remain over political uncertainty, economic crisis and surge in cases of violence and terror attacks across the country.
Bengaluru (Karnataka) [India], February 7: Bengaluru-based startup CrisprBits Private Limited, has developed OmiCrisp, a CRISPR based testing platform for rapid diagnosis and surveillance of SARS-CoV2. The CRISPR based test not only detects the virus, but also distinguishes variants of Omicr
The United States Secretary of State Antony Blinken met the Crown Prince of Saudi Arabia Mohammed bin Salman Al Saud in Riyadh on Monday and underscored the importance of addressing humanitarian needs in Gaza.
The court was hearing a petition by the Jharkhand Mukti Morcha (JMM) leader Hemant Soren who was arrested following seven hours of grilling on Wednesday evening triggering a political crisis in the state. He has been facing questions by the probe agency in an alleged money laundering case.
Rachana Reddy, Hyderabad Bharatiya Janata Party leader lashed out at the shifting of Jharkhand MLAs to Telangana, stating that by doing so the Congress-ruled state was allegedly "wasting resources".
Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.
Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.